I call this week's ranking, the "Little North American Injection Molders Ranking."
These are the companies with related sales smaller than the top 100 cut off at $72 million that ran in last week's print issue, with 481 firms combining to hit a total of $8.5 billion in sales. That's up 0.8 percent, right in line with the Top 100 with 0.7 percent.
But the true comparison of results may lie in the average sales per company. The top 100 is up 6.9 percent while the littlest gain is less than 1 percent, nearly 10 times less. We look at percentages as a way of ironing out the disparity, this gives us a relatable point of comparison, since our biggest gain here is $17 million, while the top 100 was $275 million. This week's ranking is 4-and-a-half times larger in count. That's a big power base, and calling them little makes me chuckle.
When molders report major changes in sales we look for supporting data to help explain the differences. Higher sales generally mean capacity gains or acquisitions. Looking again at the averages per company, for those reporting figures, the number of presses is up 2 percent while the number of employees is down 4.5 percent.